TUSTIN, Calif.--(BUSINESS WIRE)--Cancer patients at the CARTI Cancer Center now have access to the latest innovation in diagnostic imaging with Toshiba America Medical Systems, Inc.’s Infinix™ 4D CT. CARTI is the first healthcare provider in the United States to install the Infinix 4D CT and its unique merging of the Infinix-i angiography system and AquilionTM ONE ViSION Edition CT system that may help clinicians improve visualization and work flow, and increase patient safety.
CARTI is utilizing the system for interventional radiology and oncology to plan, treat and verify in a single clinical setting. Real CT imaging available on demand may help interventionalists improve visualization of tumors and feeder vessels, as well as provide whole organ body perfusion, to help them not only plan and treat but also verify their procedures. For example, during hepatoma embolizations, interventionalists can immediately visualize and confirm that treatment is hitting the right areas with CT, and identify feeder vessels enabling the interventionalists to guide catheters into the vessels with the angiography system’s 3D roadmap. CARTI is also using the system during liver ablations and kyphoplasty procedures, among other applications.
“Interventional radiology and oncology is born from innovation, and technology advancements like the Infinix 4D CT create exciting new possibilities and prepare us for the future of care,” said Dr. David Hays, director, Diagnostic and Interventional Radiology, CARTI. “For today’s patients, the system makes procedures that were difficult to perform and turns them into manageable cases that are easier, faster and more accurate.”
The Infinix-i enables clinicians to provide precision and flexibility during intervention with fingertip-to-fingertip and head-to-toe coverage, and enables unprecedented patient access with the Access Halo. The Aquilion ONE ViSION Edition is capable of capturing an entire organ in one rotation with 640 slices* and 16 cm of true anatomical coverage, producing image quality that far exceeds CT-like imaging of the interventional lab. The combination of the interventional lab and CT eliminates the need to transfer patients between departments and allows clinicians to decrease procedure time and maintain patient safety. Toshiba’s third-generation iterative dose reconstruction software, AIDR 3D (Adaptive Iterative Dose Reduction 3D), offers simplified CT dose reduction, while the Infinix has a suite of dose management features including the Dose Tracking System.
“CARTI is showing how real CT imaging available on demand during interventional procedures may help clinicians to improve clinical work flow, offer anatomical and functional information and reduce procedure time,” said Bill Newsom, director, X-ray Vascular Business Unit, Toshiba. “They are taking advantage of the numerous clinical applications and leveraging software like Vital’s Liver Segmentation.”
About Toshiba America Medical Systems, Inc.
With headquarters in Tustin, Calif., Toshiba America Medical Systems markets, sells, distributes and services radiology and cardiovascular systems, including CT, MR, ultrasound, X-ray and cardiovascular equipment, and coordinates clinical diagnostic imaging research for all modalities in the United States. For more information, visit Toshiba’s website at www.medical.toshiba.com.
About The CARTI Cancer Center
The CARTI Cancer Center is a 170,000 square foot, $90 million multi-specialty, patient-focused treatment facility located in Little Rock, AR, offering medical, surgical and radiation oncology and diagnostic radiology, as well as clinics dedicated to imaging, infusion, research and support programs. For more information, visit carti.com.
*with coneXact™ double slice reconstruction.